The author considers the association of antivirals for treatment of chronic hepatitis C virus (HCV) with liver cirrhosis. He offers figures about HCV-related end-stage liver disease and HCV-related decompensated cirrhosis. He mentions some key points of the American Association of Study of Liver (AASLD) guidelines for HIV-related decompensated cirrhosis.